Cinemark (NYSE:CNK) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Thursday.

According to Zacks, “CINEMARK HOLDINGS Is a leader in the motion picture exhibition industry.Cinemark operates 408 theatres and 4,657 screens in 38 states in the United States and internationally in 12 countries, mainly in Mexico, South and Central America. “

Several other equities research analysts have also commented on the stock. Morgan Stanley increased their price objective on shares of Cinemark from $40.00 to $42.00 and gave the company an “equal weight” rating in a research note on Wednesday, May 9th. Imperial Capital initiated coverage on shares of Cinemark in a research note on Wednesday, July 11th. They issued an “outperform” rating and a $46.00 price objective for the company. ValuEngine lowered shares of Cinemark from a “hold” rating to a “sell” rating in a research note on Friday, July 20th. Wedbush set a $47.00 price objective on shares of Cinemark and gave the company a “buy” rating in a research note on Friday, May 4th. Finally, B. Riley reiterated a “buy” rating on shares of Cinemark in a research note on Monday, August 6th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the stock. Cinemark has an average rating of “Hold” and an average target price of $41.63.

NYSE:CNK opened at $36.44 on Thursday. The company has a quick ratio of 1.39, a current ratio of 1.43 and a debt-to-equity ratio of 1.38. The stock has a market capitalization of $4.30 billion, a price-to-earnings ratio of 16.08, a PEG ratio of 1.20 and a beta of 0.93. Cinemark has a 52 week low of $32.03 and a 52 week high of $44.00.

Cinemark (NYSE:CNK) last posted its quarterly earnings data on Wednesday, August 8th. The company reported $0.70 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.75 by ($0.05). The firm had revenue of $889.05 million during the quarter, compared to analysts’ expectations of $897.68 million. Cinemark had a net margin of 8.86% and a return on equity of 19.49%. The company’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the business posted $0.44 EPS. equities analysts forecast that Cinemark will post 2.04 earnings per share for the current year.

Several hedge funds have recently modified their holdings of CNK. Bruderman Asset Management LLC increased its stake in shares of Cinemark by 76.6% during the 2nd quarter. Bruderman Asset Management LLC now owns 4,000 shares of the company’s stock worth $140,000 after purchasing an additional 1,735 shares during the last quarter. Holistic Financial Partners purchased a new stake in shares of Cinemark during the 1st quarter worth approximately $230,000. Itau Unibanco Holding S.A. increased its stake in shares of Cinemark by 413.6% during the 2nd quarter. Itau Unibanco Holding S.A. now owns 6,898 shares of the company’s stock worth $242,000 after purchasing an additional 5,555 shares during the last quarter. GSA Capital Partners LLP purchased a new stake in shares of Cinemark during the 2nd quarter worth approximately $266,000. Finally, Point72 Hong Kong Ltd increased its stake in shares of Cinemark by 453.8% during the 2nd quarter. Point72 Hong Kong Ltd now owns 7,880 shares of the company’s stock worth $276,000 after purchasing an additional 6,457 shares during the last quarter. Institutional investors own 96.90% of the company’s stock.

Cinemark Company Profile

Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. It operates theatres in the United States, Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao, and Paraguay. As of December 31, 2017, the company operated 533 theatres and 5,959 screens.

Further Reading: Do closed-end mutual funds pay dividends?

Get a free copy of the Zacks research report on Cinemark (CNK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Cinemark (NYSE:CNK)

Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.